aut00063 tagged posts

Autifony Tinnitus Phase ii Research

autifony tinnitus

Autifony Tinnitus (KV3) Phase ii Research- AUT00063

Autifony is known for pioneering the development of novel pharmaceutical treatments for hearing disorders and now they have moved on to the next phase in it’s tinnitus research. Autifony is studying Tinnitus Subjects with its lead compound AUT00063 as they are exploring the potential and effectiveness of...

Read More